In the vast world of the healthcare industry, doctors who play an instrumental role in patient consultation and treatment are just the tip of the iceberg. A substantial pharmaceutical industry that functions undertaking numerous decades of research, permutations, and combinations, series of experiments and tests that go into inventing new cures and vaccines on various diseases and ailments, manufacturing medicines under strictest quality norms and distributing for consumption by patients, forms the real foundation of the healthcare world.
Today, the outcome of quality healthcare has increased significantly, thanks to the developments in the breakthroughs of pharmaceutical scientists and researchers, who have contributed with their discoveries in curing and treating different health conditions. Also, the latest technology is used in the manufacture of medicines under stringent quality norms with patients as the primary objective. This is where Sharon Bio-Medicine Ltd excels as a prominent pharmaceutical solution-providing organization in manufacturing and supply of a varied product range of reliable medicines for treating various illnesses.
Steered by its dynamic CEO, Kaushik Banerjee, Sharon Bio-Medicine has significantly contributed to the manufacturing and supply of high quality, safe and effective medicines to their clients worldwide which are essential remedies prescribed by medical practitioners today.
Let’s indulge in the enthralling story of Sharon Bio-Medicine Ltd
A Humble Beginning
Sharon Bio-Medicine Ltd is an Indian Pharmaceutical Company listed on the Bombay Stock Exchange and National Stock Exchange. Over the years, it has evolved from being a manufacturer of Intermediates and Active to now providing a range of pharmaceutical products and services in contract Manufacturing of Finished Dosages and Animal toxicology and Chemistry services to its global clients.
Being in Pharma industry, patient safety and compliance assumes the highest priority along with quality, customer service and cost competitiveness as key drivers. The Company has embedded a 5 Star value system in its culture with the motto “Delivering with Values” embraced in the ways of working. Customer Excellence, Trust and Respect, Integrity & Compliance, Total Quality and Team Work are the 5 pillars of Delivering with Values.
Continuum of Genuine Excellence
Customer Service Excellence is the core of the company’s work culture. The focus is on the actions, innovation, performance, and delivering the best quality with excellent service that will earn respect and loyalty of its customers and associates.
The employees strive for continuous improvement, creating high performance, an entrepreneurial outlook, and a result-oriented approach.
The Exuberance of Trust and Respect
The organizational culture respects every individual and treats them with self-respect, esteem, and dignity. The employees demonstrate this by being honest and fair in all their dealings, conduct, and their behaviour with everyone. The management provides equal opportunities, encourages diversity in thought, and strives to recognize, develop, and reward people for their contributions.
Integrity and Compliances
Sharon, as an organization, upholds integrity in every fabric of its work areas. It encourages openness, honesty, and transparency in its dealings with all our stakeholders. It always ensures compliance with the laws of the land and maintains the highest standards of ethics, governance, and environmental health and safety.
‘Total Quality’ is the core of Sharon’s culture. It offers utmost priority in ‘Patient Care’ and imbibes high standards of quality in all aspects of its products and processes.
Sharon Bio-medicine developed a conscious system to act, innovate, perform and deliver quality excellence that will earn the respect and loyalty of its customers and, in turn, the patients.
Teamwork and Collaboration
Sharon Bio-medicine believes that teamwork and collaboration are a way of life. It encourages and rewards collaboration at every level in the organization.
The holistic approach supports sharing ideas, building strong relationships, and collective efforts will be key to organizational success. The organization focuses on working innovatively and leveraging its strengths to create a “boundary-less” culture that will empower its people to bring out the best in themselves and others.
Versatile and Effective Products
The Active Pharmaceutical Ingredient (API) products include a variety of following medicines.
- Antifungal medicines,including products Ketoconazole, Miconazole Nitrate, and Sertaconazole Nitrate
- Cardiovascular medicinescategory has products of Trimetazidine Di HCI, Nifedipine
- Anti-Depressant categorycovers products of Atomoxetine HCI, Trazodone HCI
- Anti-Alzheimercategory includes medicines of Memantine HCI
- Muscle-Relaxantsinclude Eperisone HCI
- Anti-diabeticdrug Glimepiride, GI Pro-Kinetic medicine called Mosapride Citrate Dihydrate
- Antipsychoticmedicine named Aripriprazole
The Finished Dosage Forms product list include:
|5mg, 10mg, 15mg, 30 mg
|10mg, 20mg, 40mg, 80mg
|Lipid Lowering Agent
|8mg, 16mg, 24mg
|Enalapril Maleate Tablets
|2.5mg, 5mg, 10mg, 20mg
|Lipid Lowering Agent
|125mg, 250mg, 500mg
|10mg, 25mg, 50 mg
|Loperamide HCl Capsules
|500mg , 1000mg
|10mg, 20mg, 40 mg
|Lipid Lowering Agent
|25mg, 50mg, 100 mg, 200mg
|150mg, 300 mg,
|5mg, 10mg, 20mg, 40 mg
|Lipid Lowering Agent
|2.5mg, 5mg, 10mg, 20mg
|Trazodone IR Tablets
|Trazodone MR Tablets
The Story Within
Sharon is perfectly poised for a “smooth take-off” to higher skies. Soon it is time to be a preferred choice in partnering for co-manufacturing of Oral Solid Dosage (OSDs). Sharon has gathered over two decades of experience in supplying quality, compliant products and services to global markets.
Finished Dosage Forms (FDF) Plant at the north of India (Dehradun) backward integrated to API facilities at Taloja (bordering Mumbai), investments for expansion provisions in Visakhapatnam and Maharashtra show its strategic approach and business acumen.
Reported numbers, Earnings Before Interest, Taxes, and Amortization (EBITA), and enduring global client base manifests consistency and reliability. Extensive product range, new product pipeline, and comprehensive accreditations only satisfy the confidence and encourage trustworthiness. Costs are regulated thoughtfully and not only mathematically.
Focusing on patient safety, people, and partnerships differentiates Sharon from competition. Continuous process improvement, providing end-to-end solutions, pharmaceuticals and chemistry, and engagements with customers are some key factors at Sharon which keeps us going.
The Technology Impact
The advancements in modern technologies have been thoughtfully planned and implemented in the organization, thereby improving productivity, using technology and automation, enhancing workforce efficiency, and elevating overall working speeds.
Modern enterprise resource applications have integrated all operations and brought all the departments and employees into one plane—efficient and smoother coordination with customers, employees, associates, and management.
Artificial Intelligence (AI), Machine Learning (ML), Big Data analytics applications have helped capture the working data for proper review and analysis. It further identifies the grey areas in the system and suggests new solutions for improvements. The users can document their findings and get logical conclusions without having to work on these aspects themselves and save much time in repetitive activities.
Surmounting the Challenges
Sharon Bio-Medicine has faced numerous challenges starting with financial distress 4 years ago which led to change of guard. The new Leadership team brought about a complete overhaul of all systems and processes, improved compliances with controls, optimized costs and most importantly built trust amongst Supply Chain partners and Customers as a reliable suppliers of quality medicines. This led to a full turnaround in 2 years and now going from strength to strength with double digit year on year growth in revenue and profitability.
The company faced serious Supply Chain disruption during Covid. Every industry can face supply chain problems; however, the company handled it from a learning perspective. All the experienced and ‘possibly would-be’ causes of disruption were brain-stormed by the production engineers. Certain definitive steps were implemented to ensure the production schedules’ smooth and steady functioning.
Then, while handling the shopfloor issues, the management felt the need to have a qualified workforce. New HR policies were implemented with proper impetus on the candidates’ qualifications, subject knowledge, and decision-making abilities.
The challenges further revolved around the creation, compilation, storage, analysis and retrieval of the data. A modern system was brought into force that streamlined, organized and managed the data correctly. The aspect of data security was also addressed here. A robust and flexible infrastructure was developed, synchronizing all departments towards effective workforce optimization.
Echoes of Experience
As advice to young professionals focusing on entering the bio-medicine sector, Kaushik highlights certain fundamental qualities of patience, perseverance, analysis, and scalability.
The young entrants should focus on learning and mastering the basics as the basics help in knowing and reaching the objectives. From studying the symptoms and prevailing health conditions, a logical approach is to develop the selective mode of identifying the relevant drugs that possibly can support the research experiments. Patient research on the topic from the research carried out worldwide can help understand and identify the process.
Further focusing on the production process and working on the drug’s effectiveness should be the next step. Bio-medicine field is the sector that brings up new things every time and with new challenges.
Strengthening the Future
Sharon Bio-medicine aims to earn the reputation of being a reliable manufacturer and a force to reckon with in producing chemical intermediates, bulk actives, and pharmaceutical formulations. The management focuses on becoming a benchmark for production efficiency and excellence globally. It visualizes the future as having a diverse portfolio of customers and contributing to their success as partners in progress.
Sharon Bio-Medicine Ltd is set on a mission to put its best foot forward in building core competence in drug development and manufacturing technology to develop important generic alternatives for new drugs. This includes creating an operation-oriented environment that balances key objectives, quality, and costs with a resultant outcome that gives it a competitive advantage.